Storm brews around Aduhelm as FDA requests probe; Dissecting pipeline disasters; Bob Nelsen is going Really Big; and more
Welcome back to Endpoints Weekly, your review of the week’s top biopharma headlines. Want this in your inbox every Saturday morning? Current Endpoints readers can visit their reader profile to add Endpoints Weekly. New to Endpoints? Sign up here.
As the biopharma industry booms, manufacturing drugs in the quantity and quality required are becoming increasingly crucial. If you’re interested in tracking the latest developments in that space, Kyle Blankenship and Josh Sullivan have you covered in the weekly Endpoints Manufacturing report. Check out the channel here and visit your reader profile to receive it in your inbox next Thursday.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 117,700+ biopharma pros reading Endpoints daily — and it's free.